Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients With Advanced Pulmonary Arterial Hypertension

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2014.07.185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Transition of Stable Pediatric Patients With Pulmonary Arterial Hypertension From Intravenous Epoprostenol to Intravenous Treprostinil

American Journal of Cardiology
Cardiovascular MedicineCardiology
2007English

Continuous Intravenous Epoprostenol for Pulmonary Arterial Hypertension: Highlighting Practical Issues, Special Considerations

Advances in Pulmonary Hypertension
2002English

Continuous Intravenous Epoprostenol for Chronic Thromboembolic Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2004English

Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients With Pulmonary Arterial Hypertension (EPITOME4)

Advances in Therapy
MedicinePharmacology
2013English

Epoprostenol Treatment for Idiopathic Pulmonary Arterial Hypertension in Pregnancy

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2010English

Withdrawal of Long-Term Epoprostenol Therapy in Pulmonary Arterial Hypertension (PAH)

Pulmonary Circulation
PulmonaryRespiratory Medicine
2017English

Intravenous Iron Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension and Iron Deficiency

Pulmonary Circulation
PulmonaryRespiratory Medicine
2015English

Erratum To: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients With a Pulmonary Arterial Hypertension (EPITOME4)

Advances in Therapy
MedicinePharmacology
2013English

Epoprostenol Treatment in Children With Severe Pulmonary Hypertension

Heart
Cardiovascular MedicineCardiology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy